Search - tctmd.com

Displaying 661 - 680 of 959

Sort: Relevancy | Date

News Daily News

New AHA Advisory Waffles on Artificially Sweetened Drinks, Citing Dearth of Studies

Lucy Hicks

August 07, 2018

News Daily News

After Cardiotoxic Chemo, Less Than Half of Women With Breast Cancer Get Recommended Monitoring

Caitlin E. Cox

August 06, 2018

News Daily News

Elevated High-Sensitivity CRP Lingers Long After MI, Observational Study Shows

Yael L. Maxwell

August 03, 2018

News Daily News

Starting Low and Going Lower: Some Benefit to Very Low LDL Levels

Michael O'Riordan

August 02, 2018

News Daily News

TCTMD’s Top 10 Most Popular Stories for July 2018

Shelley Wood

August 01, 2018

News Daily News

Peer Pressure May Push Physicians to Do Better at Prescribing Statins

Lucy Hicks

July 30, 2018

News Daily News

Is Weight-Based Dosing of Aspirin Needed for Effective Primary Prevention?

Todd Neale

July 20, 2018

News Conference News SCCT 2018

CAC Scoring Enthusiasts Frustrated Over ‘Disappointing’ USPSTF Recommendations

Yael L. Maxwell

July 16, 2018

News Daily News

Multivitamin and Mineral Supplements Don’t Stave Off Heart Disease or Stroke: Meta-analysis

Caitlin E. Cox

July 13, 2018

News Daily News

USPSTF: Insufficient Evidence to Support CAC Score, hsCRP, or ABI for Risk Assessment

Michael O'Riordan

July 12, 2018

News Daily News

New Review Probes Possibility of CVD Prevention Without Aspirin

Michael O'Riordan

July 04, 2018

News Daily News

Clinical Benefit of Lowering Lp(a) Is Proportional to Its Absolute Reduction: Mendelian Randomization Analysis

Yael L. Maxwell

June 25, 2018

News Daily News

Controversial Trial of Alcohol’s ‘Benefits’ for Preventing CVD Halted by NIH

Shelley Wood

June 19, 2018

News Daily News

Reduction in CVD Events, Even Mortality, in Patients With Diabetes Who Adopt a Healthier Lifestyle

Michael O'Riordan

June 18, 2018

News Daily News

Serial CTA Shines a Light on Statin Effects in Subclinical CAD

Yael L. Maxwell

June 15, 2018

News Daily News

Do Not Screen Asymptomatic Adults For CVD With ECGs, Says USPSTF

Michael O'Riordan

June 12, 2018

News Conference News EAS 2018

Glucose and Beyond? Experts Debate Optimal Targets for Managing CV Risk in Diabetics

Yael L. Maxwell

May 16, 2018

News Conference News EAS 2018

ORION 1 Data Show Lipoprotein-Lowering Beyond LDL Cholesterol With Injectable Inclisiran

Yael L. Maxwell

May 14, 2018

News Conference News EAS 2018

EAS Consensus Document Examines Safety of Statins Beyond Muscle Symptoms

Yael L. Maxwell

May 11, 2018

News Conference News EAS 2018

Unlocking Lp(a): Baseline Levels Matter, but So Too Does Absolute Reduction

Yael L. Maxwell

May 08, 2018

Advertisement

New AHA Advisory Waffles on Artificially Sweetened Drinks, Citing Dearth of Studies

After Cardiotoxic Chemo, Less Than Half of Women With Breast Cancer Get Recommended Monitoring

Elevated High-Sensitivity CRP Lingers Long After MI, Observational Study Shows

Starting Low and Going Lower: Some Benefit to Very Low LDL Levels

TCTMD’s Top 10 Most Popular Stories for July 2018

Peer Pressure May Push Physicians to Do Better at Prescribing Statins

Is Weight-Based Dosing of Aspirin Needed for Effective Primary Prevention?

CAC Scoring Enthusiasts Frustrated Over ‘Disappointing’ USPSTF Recommendations

Multivitamin and Mineral Supplements Don’t Stave Off Heart Disease or Stroke: Meta-analysis

USPSTF: Insufficient Evidence to Support CAC Score, hsCRP, or ABI for Risk Assessment

New Review Probes Possibility of CVD Prevention Without Aspirin

Clinical Benefit of Lowering Lp(a) Is Proportional to Its Absolute Reduction: Mendelian Randomization Analysis

Controversial Trial of Alcohol’s ‘Benefits’ for Preventing CVD Halted by NIH

Reduction in CVD Events, Even Mortality, in Patients With Diabetes Who Adopt a Healthier Lifestyle

Serial CTA Shines a Light on Statin Effects in Subclinical CAD

Do Not Screen Asymptomatic Adults For CVD With ECGs, Says USPSTF

Glucose and Beyond? Experts Debate Optimal Targets for Managing CV Risk in Diabetics

ORION 1 Data Show Lipoprotein-Lowering Beyond LDL Cholesterol With Injectable Inclisiran

EAS Consensus Document Examines Safety of Statins Beyond Muscle Symptoms

Unlocking Lp(a): Baseline Levels Matter, but So Too Does Absolute Reduction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content